Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-16 Purchase |
2023-06-20 08:35 am |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commerical Officer |
12,000 | $1.869 | $22,428 | 21,935 (Direct) |
View |
2022-12-19 Purchase |
2022-12-21 09:15 am |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
100,000 | $0.2448 | $24,480 | 182,056 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-31 Exercise |
2025-03-31 4:34 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
209 | $0 | 23,602 (Direct) |
View |
2025-02-20 Option Award |
2025-02-24 5:03 pm |
N/A 2035-02-19 |
Evoke Pharma Inc | EVOK | PYSZCZYMUKA GREG Director |
5,833 | $0 | 5,833 (Direct) |
View |
Ownership |
2025-02-24 5:00 pm |
N/A N/A |
Evoke Pharma Inc | EVOK | PYSZCZYMUKA GREG Director |
0 | $0 | 0 (Direct) |
View |
2024-12-31 Exercise |
2025-01-02 5:02 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
208 | $0 | 23,602 (Direct) |
View |
2024-11-06 Option Award |
2024-11-08 7:23 pm |
N/A 2034-11-06 |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
7,000 | $0 | 7,000 (Direct) |
View |
2024-09-30 Exercise |
2024-10-02 5:18 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
209 | $0 | 23,602 (Direct) |
View |
2024-06-30 Exercise |
2024-07-02 5:20 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
208 | $0 | 23,602 (Direct) |
View |
2024-03-31 Exercise |
2024-04-02 4:44 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
208 | $0 | 23,602 (Direct) |
View |
2023-12-31 Exercise |
2024-01-02 4:37 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
209 | $0 | 23,602 (Direct) |
View |
2023-09-30 Exercise |
2023-10-03 4:37 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
208 | $0 | 23,602 (Direct) |
View |
2023-08-11 Option Award |
2023-08-15 7:21 pm |
N/A 2033-08-12 |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
7,000 | $0 | 7,000 (Direct) |
View |
2023-06-30 Exercise |
2023-07-06 3:26 pm |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commerical Officer |
208 | $0 | 23,602 (Direct) |
View |
2023-04-25 Exercise |
2023-06-20 08:29 am |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commerical Officer |
833 | $0 | 11,602 (Direct) |
View |
Ownership |
2022-11-15 09:27 am |
N/A N/A |
AYTU BIOPHARMA INC | AYTU | PYSZCZYMUKA GREG Chief Commercial Officer |
0 | $0 | 272,681 (Direct) |
View |